Suppr超能文献

发现一种强效和选择性的 DDR1 受体酪氨酸激酶抑制剂。

Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.

机构信息

Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School , Charlestown, Massachusetts 02129, United States.

出版信息

ACS Chem Biol. 2013 Oct 18;8(10):2145-50. doi: 10.1021/cb400430t. Epub 2013 Aug 13.

Abstract

The DDR1 receptor tyrosine kinase is activated by matrix collagens and has been implicated in numerous cellular functions such as proliferation, differentiation, adhesion, migration, and invasion. Here we report the discovery of a potent and selective DDR1 inhibitor, DDR1-IN-1, and present the 2.2 Å DDR1 co-crystal structure. DDR1-IN-1 binds to DDR1 in the 'DFG-out' conformation and inhibits DDR1 autophosphorylation in cells at submicromolar concentrations with good selectivity as assessed against a panel of 451 kinases measured using the KinomeScan technology. We identified a mutation in the hinge region of DDR1, G707A, that confers >20-fold resistance to the ability of DDR1-IN-1 to inhibit DDR1 autophosphorylation and can be used to establish what pharmacology is DDR1-dependent. A combinatorial screen of DDR1-IN-1 with a library of annotated kinase inhibitors revealed that inhibitors of PI3K and mTOR such as GSK2126458 potentiate the antiproliferative activity of DDR1-IN-1 in colorectal cancer cell lines. DDR1-IN-1 provides a useful pharmacological probe for DDR1-dependent signal transduction.

摘要

DDR1 受体酪氨酸激酶被细胞外基质胶原激活,并与许多细胞功能相关,如增殖、分化、黏附、迁移和侵袭。在此,我们报道了一种强效且选择性的 DDR1 抑制剂 DDR1-IN-1 的发现,并展示了 2.2 Å 的 DDR1 共晶结构。DDR1-IN-1 以“DFG-out”构象结合 DDR1,并以亚微摩尔浓度抑制 DDR1 自身磷酸化,对 451 种激酶的评估具有良好的选择性,该评估使用了 KinomeScan 技术。我们鉴定了 DDR1 铰链区的 G707A 突变,该突变使 DDR1-IN-1 抑制 DDR1 自身磷酸化的能力增加了 20 多倍,可用于确定什么药理学是 DDR1 依赖性的。DDR1-IN-1 与注释激酶抑制剂文库的组合筛选显示,PI3K 和 mTOR 的抑制剂,如 GSK2126458,可增强 DDR1-IN-1 在结直肠癌细胞系中的抗增殖活性。DDR1-IN-1 为 DDR1 依赖性信号转导提供了有用的药理学探针。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验